[ET Net News Agency, 6 February 2024] CARDIOFLOW-B (02160) rose 10.9% to HK$1.32,
breaking above the 10-D SMA of HK$1.291.
It hits an intra-day high of HK$1.32, and an intra-day low of HK$1.19. The total shares
traded was 2.68 million, with a value of HK$3.35m. The active buy/sell ratio is 69:31,
with net buying turnover of HK$1.22m. J.P. MORGAN BRO (HK) accounts for greatest net
responsive buying turnover of HK$162,795, with volume weighted average price of HK$1.241.
BARCLAYS CAPITAL ASIA accounts for greatest net responsive selling turnover of HK$453,621,
with volume weighted average price of HK$1.249.
Basic Information
=================
---------------------------------
Nominal 1.320 % Chg +10.92%
High 1.320 Low 1.190
Shares Tr 2.68m Turnover 3.35m
10-D SMA 1.291 %H.V 112.512
20-D SMA 1.351 VWAP 1.250
50-D SMA 1.531 RSI14 46.121
---------------------------------
Status: Breaking above the 10-D SMA, active buy/sell ratio is 69:31, with net buying
turnover of HK$1.22m
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
CARDIOFLOW-B (02160) 1.32 +10.92
GENSCRIPT BIO (01548) 14.02 +9.36
INNOVENT BIO (01801) 32.80 +8.97
JXR (01951) 2.30 +7.48
EVEREST MED-B (01952) 16.66 +14.58
WUXI BIO (02269) 18.20 +5.20
WUXI APPTEC (02359) 49.45 +8.80
BEIGENE (06160) 89.65 +3.34
ZAI LAB (09688) 17.70 +2.31
AKESO (09926) 42.70 +9.63
---------------------------------------------
(ed)